Study Evaluating the Efficacy and Safety With CAR-T for Relapsed or Refractory Neuroblastoma in Children
Clinical trial NCT02919046 · UNKNOWN
Trial details
- NCT number
- NCT02919046
- Sponsor
- Sinobioway Cell Therapy Co., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2020-09-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.